Radical improvements in diagnostic services, cancer education, and training, and policies that encourage integration between primary and specialist care, primary care doctors could hold the key to meeting the growing demand for cancer care.
In infrequent situations in which coagulation factor replacement is needed, plasma can be vital for patients with cancer. Granulocyte transfusions may sometimes be considered for recalcitrant infections in patients with neutropenia. This article summarizes the current clinical indications and uses of RBCs, plasma, and granulocytes.
A weakened strain of Clostridium novyi-NT bacteria killed cancer cells when injected into tumors, investigators reported.
Presence of residual vein thrombosis may help determine the optimal duration of anticoagulant therapy in cancer patients with deep vein thrombosis (DVT) of the lower limbs.
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
Researchers have found that as antihistamines do their job, they also interfere with the function of myeloid-derived suppressor cells—a type of cell known to hinder the body's ability to combat tumors.
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers.
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results.
A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.
Radiolabeled agents are powerful tools to target and kill cancer cells. Three recent studies explore the benefits of adding radionuclide therapy when treating metastatic cancer.
Patients with advanced cancer who discussed end-of-life care with their doctors earlier in the course of their illness had care that was less aggressive in their last month of life and were more likely to use hospice services.
A phase I trial determined that dasatinib 150 mg daily is the optimum dose when dasatinib is combined with paclitaxel and carboplatin to treat patients with advanced or recurrent ovarian cancer.
Language barriers and the immigration status of caregivers appear to impact the care of Hispanic children with cancer and affect the experience of the families within the medical system.
More than a third of the 12.6 million cancer survivors in the United States have physical or mental health-related problems that jeopardize their overall health.
Certain analyses of cancer cells isolated from the blood could guide decisions about the ideal treatment for a patient with metastatic prostate cancer who has stopped responding to initial therapy.
Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery. The overall and cancer specific survival rates are similar for both approaches.
Fit elderly patients with non-small cell lung cancer (NSCLC) should be considered for salvage targeted therapy. Many physicians use age to decide what therapy to give their patients, since validated biomarkers to direct treatment decisions are lacking.
The plasma test VeriStrat can predict response but not survival benefit from erlotinib in patients with advanced non-small cell lung cancer (NSCLC).
A novel method has been developed to determine how ready acute myeloid leukemia (AML) cells are to die. This discovery may help to more effectively choose treatment options for patient with AML.
For female patients with an abnormal breast or cervical cancer screening result, patient navigation services help to decrease the time to diagnosis and helps vulnerable populations get the care they need in a timely manner.
Patients who live in rural areas are more likely to receive late-stage diagnoses and to die from their colon cancer, and less likely to receive an early diagnosis, chemotherapy, or thorough surgical treatment, according to a recent study presented at the 2012 Annual Clinical Congress of the American College of Surgeons.
Greater difficulty exists in finding matched, unrelated donors for nonwhite patients who are candidates for hematopoietic cell transplantation (HCT), according to a study by researchers at the Moffitt Cancer Center.
Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.
ATA guidelines for well-differentiated thyroid cancer recommend therapeutic neck dissection when the disease is clinically involved or metastatic and prophylactic central neck dissection when tumors are advanced. Nonetheless, though these established guidelines are in place, the surgical management of cervical nodes varies greatly.
Survivors cite lack of cancer expertise, continuity of care as barriers to role of primary care doctors.
A new study suggests radiotherapy may hold clinical promise for the control of local lymph node bed recurrence of malignant melanoma.
People with cancer and their caregivers can turn to a new Web site to help answer the question from concerned relatives and friends, "What can I do to help?"
What are the best ways to combine good medical practice with good medico‑legal and legal practice in an era of 21st century cancer medicine?
ASCO recommends offering palliative care to all patients with metastatic or advanced cancer, ideally at diagnosis.
The Agency for Healthcare Research and Quality (AHRQ) released Statistical Brief #125 Cancer Hospitalizations for Adults, 2009.
Sign Up for Free e-newsletters
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- USPSTF Still Recommends Against Pancreatic Cancer Screening
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
- Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer
- Sharing Personal Contact Information With Patients
- Country-Specific Norms Created for Cancer-Related Quality of Life
- Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|